Elicera Therapeutics AB (publ)

OM:ELIC Stock Report

Market Cap: SEK 60.9m

Elicera Therapeutics Management

Management criteria checks 2/4

Elicera Therapeutics' CEO is Jamal El-Mosleh, appointed in Jan 2020, has a tenure of 4.83 years. directly owns 8.39% of the company’s shares, worth SEK5.11M. The average tenure of the management team and the board of directors is 4.3 years and 4.8 years respectively.

Key information

Jamal El-Mosleh

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.8yrs
CEO ownership8.4%
Management average tenure4.3yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO

Jamal El-Mosleh (43 yo)

4.8yrs

Tenure

Mr. Jamal El-Mosleh, M.Sc., is Co-Founder at Elicera Therapeutics AB (publ) and has been its CEO since 2020. He was a Director of Elypta AB since 2016 until September 2020. Mr. El-Mosleh served as Chief Ex...

Leadership Team

NamePositionTenureCompensationOwnership
Jamal El-Mosleh
CEO & Co-Founder4.8yrsno data8.39%
SEK 5.1m
Magnus Essand
Chief Science Officer4.8yrsno data9.6%
SEK 5.8m
Di Yu
Co-Founder & Head of Transitional Researchno datano data9.76%
SEK 5.9m
Ingvar Karlsson
Chief Financial Officer3.8yrsno data0.10%
SEK 62.5k
Anna Gultekin
Head of Regulatory Affairs1.8yrsno datano data

4.3yrs

Average Tenure

51.5yo

Average Age

Experienced Management: ELIC's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Magnus Essand
Chief Science Officer10.8yrsno data9.6%
SEK 5.8m
Margareth Jorvid
Independent Director4.8yrsno data0.20%
SEK 119.0k
Agneta Edberg
Independent Chairman4.8yrsno data0.34%
SEK 208.7k
Christina Herder
Independent Director4.8yrsno data0.16%
SEK 98.0k
Sharon Longhurst
Independent Directorless than a yearno datano data

4.8yrs

Average Tenure

63yo

Average Age

Experienced Board: ELIC's board of directors are considered experienced (4.8 years average tenure).